Michael Ehrlich M.D.

Michael Ehrlich MD, MBA is an accomplished medical professional with extensive experience in ophthalmology and clinical development. Currently serving as an Entrepreneur in Residence at Yale Ventures since July 2024, Michael supports Yale innovators in biotech startups. As the Executive Director of Clinical Development for Ophthalmology and Neurology at Alexion Pharmaceuticals since March 2022, Michael leads global program teams and oversees medical strategy. Michael has been a part of Yale New Haven Health's honorary medical staff since June 2017. Prior roles include Senior Clinical Program Leader in Ophthalmology at Boehringer Ingelheim and Assistant Professor of Ophthalmology at Yale School of Medicine. Michael's educational background includes an M.D. from Thomas Jefferson University, an Executive MBA from Quantic School of Business and Technology, and a Bachelor’s degree in Public Policy Analysis from Duke University. Recognized as a Connecticut Magazine Top Doctor in 2016 and 2017, Michael also directed the Oculoplastic Fellowship at Yale Eye Center.